This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert V. Johnson, MD; Steven M. Donn, MD

Am J Dis Child. 1988;142(9):968-971.

Abstract
• Peripheral intravenous cannula use in a neonatal Intensive care unit was surveyed prospectively to ascertain the rate of complications and the factors influencing the life span of an intravenous cannula. During a three-month period in which 199 intravenous cannulas were inserted in 69 patients, only two significant infiltrations (1%) were observed in more than 5000 hours of intravenous therapy. None of the factors studied, including weight, age, type and rate of fluid administration, and type of medication (except pancuronium bromide), had any discernible effect on the functional life span of intravenous cannulas. Pancuronium was associated with a significant prolongation of cannula life span—from 30 to 50 hours. We conclude that in this setting, the rate of clinically significant complications from intravenous cannula therapy is low.

(AJDC 1988;142:968-971)

Author Affiliations
From the Department of Pediatrics, Section of Newborn Services, University of Michigan Medical Center, Ann Arbor. Dr Johnson is now with the Mayo Clinic, Rochester, Minn.

Footnotes
Accepted for publication April 26, 1988.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Limb splinting for intravenous cannulae in neonates: a randomised controlled trial
Dalal et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2009;94:F394-F396.
ABSTRACT | FULL TEXT